金投网

Beneficiary on the optical feature upgrade trend

  舜宇光学科技(02382)   We spoke to Sunny Optical, and provide a company update here. Thecompany highlights meaningful HoH/YoY margin increase in 2H16, driven bydual camera lens/vehicles lens growth. Mgmt anticipates the magnitude ofprofit increase will surpass top line growth in 2017, driven by marginexpansion on improved product mix. The rising OIS bundle rate on smartphonedual camera will further enhance its market share expansion in both lens andCCM segments owing to its vertical integration and optical alignment knowhow.Reiterate Buy rating.   Sunny achieves initial break-through in dual-camera lens set. It has beenqualified by Chinese handset customers with shipment starting from Oct.Driven by the favorable product mix change, mgmt expects lens set GPM to hit40%+ in 2H16 vs. 35% in 1H16. Also, Sunny is engaged in the optical zoomtype (3 times) dual cameras design with several customers. Sunny believesimproving sales mix towards high-end product will lead to margin expansion incoming year.   Propelled by key customers' new premium dual camera phone launch (HuaweiMate9), Sunny indicates that 10MP+ CCM shipment will account for 60%+ oftotal CCM shipment in 2H16. Due to higher precision requirement, Sunny iswinning shares from its major competitor (Lite-On, in our view) on Huaweihigh-end projects, and gets dominant order allocation (50%+), thanks to itsoptical alignment technology strength. The firm is generating at least low teens GPM from dual CCM projects, which will accelerate overall CCM margingrowth. Mgmt has seen rising OIS dual camera demand and believes the ASPhike (30%+ higher) will accordingly stimulate CCM revenue increase in 2017.   Our TP of HKD40, still based on 0.7x PEG (or 22x PER), in line with regionalpeers. We believe this valuation is justified by an improving sector growthoutlook and Sunny’s market share gain potential. Downside risks: marketshare loss and fiercer-than-expected competition in the CCM field.
免责声明 金投网发布此信息目的在于传播更多信息,与本网站立场无关。金投网不保证该信息(包括但不限于文字、数据及图表)全部或者部分内容的准确性、真实性、完整性、有效性、及时性、原创性等。相关信息并未经过本网站证实,不对您构成任何投资建议,据此操作,风险自担。
代码 名称 最新价(港元) 涨幅
02708 艾伯科技 0.05 164.71
01708 三宝科技 0.92 48.39
00020 会德丰 1.19 43.37
08161 医汇集团 0.43 43.33
08316 柏荣集团控股 1.5 36.36

港股频道HKSTOCK.CNGOLD.ORG